iTeos Therapeutics
Biotechnology ResearchView the employees at
iTeos Therapeutics-
Chiara Martinoli Translational Medicine Consultant
-
Milan, Lombardy, Italy
-
Top 10%
Hussein Shehade Senoir Scientist at iTeos Therapeutics-
Brussels Metropolitan Area
-
Top 10%
Noémie N. Clinical Feasibility Manager chez iTeos Therapeutics-
Namur, Walloon Region, Belgium
-
Rising Star
Valerie Roobrouck Biomarker Lead, Immuno-oncology-
Leuven, Flemish Region, Belgium
-
Rising Star
Overview
iTeos Therapeutics is a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of immuno-oncology therapeutics for patients. iTeos Therapeutics leverages its deep understanding of tumor immunology and immunosuppressive pathways to design novel product candidates with the potential to restore the immune response against cancer. The Company’s innovative pipeline includes three clinical-stage programs targeting novel, validated immuno-oncology pathways designed with optimized pharmacologic properties for improved clinical outcomes, including the TIGIT:CD226 axis and the adenosine pathway. iTeos Therapeutics is headquartered in Watertown, MA with a research center in Gosselies, Belgium.
-